As per the latest market research conducted by FMI, the global microneedle drug delivery systems market is expected to record a CAGR of 6.6% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 768.9 million. By 2033, the valuation is anticipated to reach US$ 1459.1 million.
In order to administer enough doses of medication to have the desired therapeutic effect, hundreds of microneedles are arranged in arrays on a small patch. As a result, there is now a direct route for a medication to enter the viable epidermis without coming into contact with the nerves and blood vessels found in the dermal layers. Depending on their qualities, numerous types of materials, including ceramic, silicon, silica glass, carbohydrates, and polymers, are utilized to make microneedles, thus driving the microneedling tool market in the coming years. Typically, microneedles measure hundreds of microns in length, 1 to 50 micrometers in width at the tip, and 50 to 300 micrometers in length at the base.
Significant Market Trends:
Attributes | Value |
---|---|
Microneedle Drug Delivery Systems Value (2022) | US$ 722.2 million |
Microneedle Drug Delivery Systems Market Expected Value (2023) | US$ 768.9 million |
Microneedle Drug Delivery Systems Market Forecast Value (2033) | US$ 1459.1 million |
Microneedle Drug Delivery Systems Market Expected CAGR (2023 to 2033) | 6.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 6.46% |
H1, 2022 Projected | 6.60% |
H1, 2022 Outlook | 6.10% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 50 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (-) 36 ↓ |
The comparative analysis and market growth rate of the global microneedle drug delivery systems market as studied by Future Market Insights shows a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 50 BPS, and, a decline in the BPS growth is expected in H1-2022 over H1- 2021 duration with 36 basis point share (BPS).
The expensive costs of creating a reproducible microneedle patch as well as the high expenses of storing and packaging microneedles for safe distribution are also factors that have been cited as limiting the decline in BPS levels.
The market is expected to gain momentum towards expansion over the anticipated years thanks to the advantages of microneedles in advanced transdermal drug administration, including enhanced bioavailability of pharmaceuticals, reduced side effects, and rapid beginning of therapeutic action. The introduction of solid, dissolving, and coated microneedles for efficient transdermal drug administration is one of the market's major advances. With regard to medication safety and product licensing operations, the market for microneedle drug delivery systems is subject to changes based on regulatory and industry dynamics.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Demand for Microneedles for Drug Delivery is Being Driven by an Increase in Cancer Patients
The demand for innovative and efficient drug delivery methods to enhance therapy is being driven by the rising prevalence of chronic diseases in the United States, including diabetes and cancer. As a result, businesses and research organizations are bringing new product development to the nation, establishing it as a profitable segment.
In 2022, the United States witnessed 1.9 million new cancer cases diagnosed and 609,360 cancer deaths, according to Cancer Facts & Figures (2022), an educational companion to Cancer Statistics (2022), an article published in the American Cancer Society journal. This is expected to encourage the development of new oncology treatments, driving the market for microneedle drug delivery systems in the country.
Demand for High-Quality Drugs & Access to Low-Cost Raw Ingredients Allows China to Expand its Industry
China is anticipated to hold a significant position in the East Asia market over the projection period. China's government organizations are investing more money in developing the healthcare industry, which is fostering the production of novel pharmaceuticals therein.
Several international pharmaceutical companies are looking to expand their operations in China due to the abundance of low-cost raw materials and the increased demand for generic medicines.
Country | United States |
---|---|
CAGR (2018 to 2022) | 5.1% |
CAGR (2023 to 2033) | 5.7% |
Valuation (2033) | US$ 528.6 million |
Country | United Kingdom |
---|---|
CAGR (2018 to 2022) | 6.4% |
CAGR (2023 to 2033) | 7.0% |
Valuation (2033) | US$ 84.4 million |
Country | China |
---|---|
CAGR (2018 to 2022) | 5.7% |
CAGR (2023 to 2033) | 6.2% |
Valuation (2033) | US$ 77.1 million |
Country | Germany |
---|---|
CAGR (2018 to 2022) | 4.7% |
CAGR (2023 to 2033) | 5.1% |
Valuation (2033) | US$ 79.3 million |
Solid Microneedles Dominate the Development of Microneedle Drug Delivery Devices
Solid microneedles remain the market leader despite a slight decline in market share during the anticipated time frame. They are anticipated to have covered more than 50% of the market by the end of 2033. In the meantime, hollow and dissolving microneedles are anticipated to proliferate more quickly with the usage of new technologies and uses.
Research on solid microneedles is now being conducted for several applications in an effort to increase their consistency, stability, and affordability. At the moment, research is concentrated on the creation of a microneedle array.
Hospitals Set to Account for Higher Consumption of Microneedles for Drug Delivery
In 2022, hospitals held a top position as end users, accounting for 44.1% of the global market. The expansion of the worldwide microneedle drug delivery systems market is anticipated to be aided by specialty clinics.
Specialty clinics held a 22% market share globally in 2022. As more clinics focus on particular disorders, the market potential is anticipated to rise in the future. For instance, one of the biggest consumers of microneedle drug delivery devices for procedures like hair restoration, facelifts, and wrinkle therapy are cosmetic clinics. Which is expected to eventually drive the microneedling for hair loss market.
The global microneedle drug delivery systems market is dominated by large- and medium-sized companies. However, it is led by a few important companies that, as part of their marketing strategy, are focusing on their market and value chain positions. Prominent market players use a range of tactics, such as early market entry, deep market penetration, as well as exclusive marketing and distribution licensing. Product innovation and differentiation, however, are essential market strategies for both mid-size and large businesses due to the diversity of market players.
Regardless of their size, companies use distribution rights acquisition and exclusive technology licensing as core strategies. In particular, a few businesses are focusing on strategic alliances in order to get a competitive edge.
Leading companies that sell microneedle drug delivery equipment are concentrating on Research and Development to introduce cutting-edge items in the market. In order to obtain a competitive edge in the market, firms are also engaging in mergers, acquisitions, and collaborations.
Attribute | Details |
---|---|
Forecast Period | 2023 to 2033 |
Historical Data Available for | 2018 to 2022 |
Market Analysis | US$ million for Value |
Key Regions Covered |
|
Key Countries Covered |
|
Key Market Segments Covered |
|
Key Companies Profiled |
|
Pricing | Available upon Request |
The market may register a revenue of US$ 768.9 million in 2023.
The United States is the leading country in the market.
China is the leading market and is expected to grow at 6.2% until 2033.
The solid microneedle segment dominates and could hold 50% of the global market by 2033.
The hospitals segment accounted the top position with 44.1% market share in 2022.
1. Executive Summary | Microneedle Drug Delivery Systems Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033 5.3.1. Solid Microneedles 5.3.1.1. Silicon 5.3.1.2. Metal 5.3.1.3. Polymer 5.3.2. Hollow Microneedles 5.3.3. Dissolving Microneedles 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End Use 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End Use, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End Use, 2023 to 2033 6.3.1. Hospitals 6.3.2. Ambulatory Surgical Centers 6.3.3. Specialty Clinics 6.3.4. Academic Institutions 6.3.5. Research Institutes 6.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. South Asia 7.3.5. East Asia 7.3.6. Oceania 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Product 8.2.3. By End Use 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Product 8.3.3. By End Use 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Product 9.2.3. By End Use 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By End Use 9.4. Key Takeaways 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. United Kingdom 10.2.1.2. Spain 10.2.1.3. Germany 10.2.1.4. Italy 10.2.1.5. France 10.2.1.6. Rest of Europe 10.2.2. By Product 10.2.3. By End Use 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By End Use 10.4. Key Takeaways 11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. India 11.2.1.2. Malaysia 11.2.1.3. Indonesia 11.2.1.4. Thailand 11.2.1.5. Rest of South Asia 11.2.2. By Product 11.2.3. By End Use 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By End Use 11.4. Key Takeaways 12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Product 12.2.3. By End Use 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By End Use 12.4. Key Takeaways 13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Product 13.2.3. By End Use 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By End Use 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. South Africa 14.2.1.2. GCC Countries 14.2.1.3. Rest of Middle East and Africa 14.2.2. By Product 14.2.3. By End Use 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By End Use 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Product 15.1.2.2. By End Use 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Product 15.2.2.2. By End Use 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Product 15.3.2.2. By End Use 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Product 15.4.2.2. By End Use 15.5. United Kingdom 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Product 15.5.2.2. By End Use 15.6. Spain 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Product 15.6.2.2. By End Use 15.7. Germany 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Product 15.7.2.2. By End Use 15.8. Italy 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Product 15.8.2.2. By End Use 15.9. France 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Product 15.9.2.2. By End Use 15.10. India 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Product 15.10.2.2. By End Use 15.11. Malaysia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Product 15.11.2.2. By End Use 15.12. Indonesia 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Product 15.12.2.2. By End Use 15.13. Thailand 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Product 15.13.2.2. By End Use 15.14. China 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Product 15.14.2.2. By End Use 15.15. Japan 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Product 15.15.2.2. By End Use 15.16. South Korea 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Product 15.16.2.2. By End Use 15.17. Australia 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Product 15.17.2.2. By End Use 15.18. New Zealand 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Product 15.18.2.2. By End Use 15.19. South Africa 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Product 15.19.2.2. By End Use 15.20. GCC Countries 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Product 15.20.2.2. By End Use 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Product 16.3.3. By End Use 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. 3M Company 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Becton, Dickinson and Company 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Zosano Pharma Corporation 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. RAPHAS Co., Ltd. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Nanopass Tech 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Corium International, Inc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Valeritas, Inc. 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Nitto Denko Corporation 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Microdermics, Inc. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. TheraJect Inc. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Vaxxas Pty Ltd. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. Endoderma Ltd. 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.13. QuadMedicine 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.14. SNvia Co., Ltd. 17.1.14.1. Overview 17.1.14.2. Product Portfolio 17.1.14.3. Profitability by Market Segments 17.1.14.4. Sales Footprint 17.1.14.5. Strategy Overview 17.1.14.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports